PT887349E - Derivados de tetra-hidro-imidazo¬2,1-a|isoquinolina - Google Patents

Derivados de tetra-hidro-imidazo¬2,1-a|isoquinolina

Info

Publication number
PT887349E
PT887349E PT98202076T PT98202076T PT887349E PT 887349 E PT887349 E PT 887349E PT 98202076 T PT98202076 T PT 98202076T PT 98202076 T PT98202076 T PT 98202076T PT 887349 E PT887349 E PT 887349E
Authority
PT
Portugal
Prior art keywords
isokinoline
imidazone
hydro
tetra
derivatives
Prior art date
Application number
PT98202076T
Other languages
English (en)
Inventor
Gerardus Stephanus Franc Ruigt
Dirk Leysen
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PT887349E publication Critical patent/PT887349E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT98202076T 1997-06-26 1998-06-23 Derivados de tetra-hidro-imidazo¬2,1-a|isoquinolina PT887349E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201950 1997-06-26

Publications (1)

Publication Number Publication Date
PT887349E true PT887349E (pt) 2002-04-29

Family

ID=8228485

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98202076T PT887349E (pt) 1997-06-26 1998-06-23 Derivados de tetra-hidro-imidazo¬2,1-a|isoquinolina

Country Status (27)

Country Link
US (1) US5994366A (pt)
EP (1) EP0887349B1 (pt)
JP (1) JP4339939B2 (pt)
KR (1) KR100540317B1 (pt)
CN (1) CN1139589C (pt)
AR (1) AR013132A1 (pt)
AT (1) ATE209649T1 (pt)
AU (1) AU737924B2 (pt)
BR (1) BR9802286A (pt)
CA (1) CA2241469C (pt)
CZ (1) CZ293265B6 (pt)
DE (1) DE69802624T2 (pt)
DK (1) DK0887349T3 (pt)
ES (1) ES2169471T3 (pt)
HK (1) HK1018059A1 (pt)
HU (1) HUP9801451A3 (pt)
ID (1) ID20494A (pt)
IL (1) IL124914A (pt)
NO (1) NO311028B1 (pt)
NZ (1) NZ330722A (pt)
PL (1) PL190281B1 (pt)
PT (1) PT887349E (pt)
RU (1) RU2204560C2 (pt)
SG (1) SG66484A1 (pt)
TR (1) TR199801175A1 (pt)
TW (1) TW513411B (pt)
ZA (1) ZA985559B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20060653A1 (es) * 2004-08-31 2006-09-27 Glaxo Group Ltd Derivados triciclicos condensados como moduladores del receptor 5-ht1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624093A (en) * 1970-03-10 1971-11-30 American Home Prod 5,6-disubstituted-2,3,5,6-tetrahydroimidazo-{8 2,1-{60 {9 isoquinolin-6-ols
US4100165A (en) * 1975-06-17 1978-07-11 Sandoz, Inc. Imidazo [2,1-a]isoquinolines

Also Published As

Publication number Publication date
HUP9801451A2 (hu) 1999-02-01
TR199801175A1 (xx) 1999-01-18
KR19990007323A (ko) 1999-01-25
HK1018059A1 (en) 1999-12-10
SG66484A1 (en) 1999-07-20
CZ204898A3 (cs) 1999-08-11
IL124914A0 (en) 1999-01-26
HUP9801451A3 (en) 1999-03-29
EP0887349B1 (en) 2001-11-28
CN1203916A (zh) 1999-01-06
NO982952L (no) 1998-12-28
NO982952D0 (no) 1998-06-25
NO311028B1 (no) 2001-10-01
ES2169471T3 (es) 2002-07-01
DE69802624D1 (de) 2002-01-10
JPH1171373A (ja) 1999-03-16
EP0887349A1 (en) 1998-12-30
US5994366A (en) 1999-11-30
RU2204560C2 (ru) 2003-05-20
KR100540317B1 (ko) 2006-04-17
ZA985559B (en) 1999-01-20
TW513411B (en) 2002-12-11
AU737924B2 (en) 2001-09-06
CA2241469C (en) 2008-08-19
PL327053A1 (en) 1999-01-04
NZ330722A (en) 1999-08-30
DE69802624T2 (de) 2002-08-01
DK0887349T3 (da) 2002-03-25
ATE209649T1 (de) 2001-12-15
IL124914A (en) 2000-10-31
HU9801451D0 (en) 1998-08-28
BR9802286A (pt) 2000-02-08
CA2241469A1 (en) 1998-12-26
AU7319698A (en) 1999-01-07
CZ293265B6 (cs) 2004-03-17
PL190281B1 (pl) 2005-11-30
CN1139589C (zh) 2004-02-25
AR013132A1 (es) 2000-12-13
JP4339939B2 (ja) 2009-10-07
ID20494A (id) 1998-12-31

Similar Documents

Publication Publication Date Title
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
NL300150I2 (nl) 4 "-Gesubstitueerde 9-deoxo-9A-AZA-9A-homoërythromycine-A-derivaten.
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
PT1005446E (pt) Derivados de n-aroilfenilalanina
ATE235220T1 (de) Resorcinderivate
ID22781A (id) Turunan-turunan nikotinamida
DE69817186D1 (de) Diaminorhodamin-derivate
PT915088E (pt) Derivados de d-prolina
DK0966477T3 (da) 3'-N-oxid, 3'-N-dimethylamin, 9-oxim-erythromycin A-derivater
PT1003719E (pt) Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida
ATE257484T1 (de) 6,9-verbrückte erythromycin-derivate
PT1027362E (pt) Derivados de cetolidos 2-halogeno-6-o-substituidos
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
EE200000447A (et) 1,3,4-oksadiasolooni derivaadid
DE69829682D1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin-derivate
MA26480A1 (fr) Derives de phenoxymethylpiperidine
DE69828780D1 (de) Amidinocamptpthecin-derivate
PT966437E (pt) Derivados de 5-aroilnaftaleno
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
DK1015447T3 (da) Piperidinylmethyloxazolidinonderivat